Antimicrobial effect of photodynamic therapy using high-power blue light-emitting diode and red-dye agent on Porphyromonas gingivalis

Journal of Periodontal Research

Volumn 48, Issue 6, 2013, Pages 696-705

  Chui, C ^a   Aoki, A ^a   Takeuchi, Y ^a   Sasaki, Y ^a   Hiratsuka, K ^b   Abiko, Y ^b   Izumi, Y ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b NIHON UNIVERSITY   (Japan)

Author keywords

Antimicrobial photodynamic therapy; Blue light emitting diode; Porphyromonas gingivalis; rose bengal

Indexed keywords

ANTIINFECTIVE AGENT; COLORING AGENT; ERYTHROSINE; FLUORESCEIN DERIVATIVE; FLUORESCENT DYE; PHLOXINE; PHOTOSENSITIZING AGENT; ROSE BENGAL; TOLONIUM CHLORIDE;

ANTIMICROBIAL PHOTODYNAMIC THERAPY; ARTICLE; BACTERIAL LOAD; BLUE LIGHT-EMITTING DIODE; DRUG EFFECT; EQUIPMENT; HUMAN; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; PHOTOCHEMOTHERAPY; PORPHYROMONAS GINGIVALIS; TEMPERATURE;

ANTIMICROBIAL PHOTODYNAMIC THERAPY; BLUE LIGHT-EMITTING DIODE; PORPHYROMONAS GINGIVALIS; ROSE BENGAL;

ANTI-INFECTIVE AGENTS; BACTERIAL LOAD; BACTERIOLOGICAL TECHNIQUES; COLORING AGENTS; ERYTHROSINE; FLUORESCEINS; FLUORESCENT DYES; HUMANS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYROMONAS GINGIVALIS; ROSE BENGAL; TEMPERATURE; TOLONIUM CHLORIDE;

EID: 84887157000     PISSN: 00223484     EISSN: 16000765     Source Type: Journal    
DOI: 10.1111/jre.12055     Document Type: Article

References (43)

1. Amano A. Disruption of epithelial barrier and impairment of cellular function by Porphyromonas gingivalis. Front Biosci 2007;12:3965-3974.
2. Socransky SS, Haffajee AD. Dental biofilms: difficult therapeutic targets. Periodontol 2000 2002;28:12-55.
3. Pallasch TJ. Antibiotic resistance. Dent Clin North Am 2003;47:623-639.
4. Quirynen M, Teughels W, van Steenberghe D. Microbial shifts after subgingival debridement and formation of bacterial resistance when combined with local or systemic antimicrobials. Oral Dis 2003;9(suppl 1):30-37.
5. Rodrigues RM, Goncalves C, Souto R, Feres-Filho EJ, Uzeda M, Colombo AP. Antibiotic resistance profile of the subgingival microbiota following systemic or local tetracycline therapy. J Clin Periodontol 2004;31:420-427.
6. Walker CB. The acquisition of antibiotic resistance in the periodontal microflora. Periodontol 2000 1996;10:79-88.
7. Grenier D, La VD. Proteases of Porphyromonas gingivalis as important virulence factors in periodontal disease and potential targets for plant-derived compounds: a review article. Curr Drug Targets 2011;12:322-331.
8. Laugisch O, Schacht M, Guentsch A et al. Periodontal pathogens affect the level of protease inhibitors in gingival crevicular fluid. Mol Oral Microbiol 2012;27:45-56.
9. Chui C, Hiratsuka K, Aoki A, Takeuchi Y, Abiko Y, Izumi Y. Blue LED inhibits the growth of Porphyromonas gingivalis by suppressing the expression of genes associated with DNA replication and cell division. Lasers Surg Med 2012;44:856-864.
10. Aoki A, Mizutani K, Takasaki AA et al. Current status of clinical laser applications in periodontal therapy. Gen Dent 2008;56:674-687.
11. Aoki A, Sasaki KM, Watanabe H, Ishikawa I. Lasers in nonsurgical periodontal therapy. Periodontol 2000 2004;36:59-97.
12. Ishikawa I, Aoki A, Takasaki AA, Mizutani K, Sasaki KM, Izumi Y. Application of lasers in periodontics: true innovation or myth? Periodontol 2000 2009;50:90-126.
13. Wigdor H, Abt E, Ashrafi S, Walsh JT Jr. The effect of lasers on dental hard tissues. J Am Dent Assoc 1993;124:65-70.
14. Foote CS. Definition of type I and type II photosensitized oxidation. Photochem Photobiol 1991;54:659.
15. Konopka K, Goslinski T. Photodynamic therapy in dentistry. J Dent Res 2007;86:694-707.
16. Sharman WM, Allen CM, van Lier JE. Photodynamic therapeutics: basic principles and clinical applications. Drug Discov Today 1999;4:507-517.
17. Takasaki AA, Aoki A, Mizutani K et al. Application of antimicrobial photodynamic therapy in periodontal and peri-implant diseases. Periodontol 2000 2009;51:109-140.
18. Sigusch BW, Engelbrecht M, Volpel A, Holletschke A, Pfister W, Schutze J. Full-mouth antimicrobial photodynamic therapy in Fusobacterium nucleatum-infected periodontitis patients. J Periodontol 2010;81:975-981.
19. Enwemeka CS, Williams D, Enwemeka SK, Hollosi S, Yens D. Blue 470-nm light kills methicillin-resistant Staphylococcus aureus (MRSA) in vitro. Photomed Laser Surg 2009;27:221-226.
20. Enwemeka CS, Williams D, Hollosi S, Yens D, Enwemeka SK. Visible 405 nm SLD light photo-destroys methicillin-resistant Staphylococcus aureus (MRSA) in vitro. Lasers Surg Med 2008;40:734-737.
21. Guffey JS, Wilborn J. Effects of combined 405-nm and 880-nm light on Staphylococcus aureus and Pseudomonas aeruginosa in vitro. Photomed Laser Surg 2006;24:680-683.
22. Papageorgiou P, Katsambas A, Chu A. Phototherapy with blue (415 nm) and red (660 nm) light in the treatment of acne vulgaris. Br J Dermatol 2000;142:973-978.
23. Umeda M, Ishikawa I, Benno Y, Mitsuoka T. Improved detection of oral spirochetes with an anaerobic culture method. Oral Microbiol Immunol 1990;5:90-94.
24. Arakane K, Ryu A, Hayashi C et al. Singlet oxygen (1 delta g) generation from coproporphyrin in Propionibacterium acnes on irradiation. Biochem Biophys Res Commun 1996;223:578-582.
25. Feuerstein O, Persman N, Weiss EI. Phototoxic effect of visible light on Porphyromonas gingivalis and Fusobacterium nucleatum: an in vitro study. Photochem Photobiol 2004;80:412-415.
26. Nussbaum EL, Lilge L, Mazzulli T. Effects of 630-, 660-, 810-, and 905-nm laser irradiation delivering radiant exposure of 1-50 J/cm2 on three species of bacteria in vitro. J Clin Laser Med Surg 2002;20:325-333.
27. Nussbaum EL, Lilge L, Mazzulli T. Effects of 810 nm laser irradiation on in vitro growth of bacteria: comparison of continuous wave and frequency modulated light. Lasers Surg Med 2002;31:343-351.
28. Ganz RA, Viveiros J, Ahmad A et al. Helicobacter pylori in patients can be killed by visible light. Lasers Surg Med 2005;36:260-265.
29. Guffey JS, Wilborn J. In vitro bactericidal effects of 405-nm and 470-nm blue light. Photomed Laser Surg 2006;24:684-688.
30. Soukos NS, Som S, Abernethy AD et al. Phototargeting oral black-pigmented bacteria. Antimicrob Agents Chemother 2005;49:1391-1396.
31. Goulart Rde C, Thedei G Jr, Souza SL, Tedesco AC, Ciancaglini P. Comparative study of methylene blue and erythrosine dyes employed in photodynamic therapy for inactivation of planktonic and biofilm-cultivated Aggregatibacter actinomycetemcomitans. Photomed Laser Surg 2010;28(Suppl 1):S85-S90.
32. Rossoni RD, Junqueira JC, Santos EL, Costa AC, Jorge AO. Comparison of the efficacy of Rose Bengal and erythrosin in photodynamic therapy against Enterobacteriaceae. Lasers Med Sci 2010;25:581-586.
33. Rasooly A, Weisz A. In vitro antibacterial activities of phloxine B and other halogenated fluoresceins against methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2002;46:3650-3653.
34. Goulart Rde C, Bolean M, Paulino Tde P et al. Photodynamic therapy in planktonic and biofilm cultures of Aggregatibacter actinomycetemcomitans. Photomed Laser Surg 2010;28(Suppl 1):S53-S60.
35. Kato H, Komagoe K, Nakanishi Y, Inoue T, Katsu T. Xanthene dyes induce membrane permeabilization of bacteria and erythrocytes by photoinactivation. Photochem Photobiol 2012;88:423-431.
36. Ishiyama K, Nakamura K, Ikai H et al. Bactericidal action of photogenerated singlet oxygen from photosensitizers used in plaque disclosing agents. PLoS ONE 2012;7:e37871.
37. Bhatti M, MacRobert A, Meghji S, Henderson B, Wilson M. A study of the uptake of toluidine blue O by Porphyromonas gingivalis and the mechanism of lethal photosensitization. Photochem Photobiol 1998;68:370-376.
38. Yamamoto J, Yamamoto S, Hirano T et al. Monitoring of singlet oxygen is useful for predicting the photodynamic effects in the treatment for experimental glioma. Clin Cancer Res 2006;12:7132-7139.
39. Ogawa Y, Okamoto S, Mori T et al. Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease. Bone Marrow Transplant 2003;31:579-583.
40. Kim YS, Rubio V, Qi J et al. Cancer treatment using an optically inert Rose Bengal derivative combined with pulsed focused ultrasound. J Control Release 2011;156:315-322.
41. Wang XL, Zeng Y, Zheng YZ et al. Rose bengal-grafted biodegradable microcapsules: singlet-oxygen generation and cancer-cell incapacitation. Chemistry 2011;17:11223-11229.
42. Tsao S, Yao M, Tsao H et al. Light-activated tissue bonding for excisional wound closure: a split-lesion clinical trial. Br J Dermatol 2012;166:555-563.
43. Trindade FZ, Pavarina AC, Ribeiro AP, Bagnato VS, Vergani CE, Costa CA. Toxicity of photodynamic therapy with LED associated to Photogem(R): an in vivo study. Lasers Med Sci 2012;27:403-411.